It is focusing on announcing the results of the MFDS. Anxiety in production and sales sites surrounding Losartan impurities is rising. As self-inspection results begin to come out for each manufacturer, consignment companies that received these results are agonizing over whether to preemptively suspend sales or continue sales.

According to the pharmaceutical industry on the 24th, Arlico Pharmaceutical, Aju, and CTC Bio decided to stop selling Losartan-containing products. In the case of Arlico, the company decided to voluntarily withdraw along with the suspension of sales. At least five companies are confirmed to have officially decided to suspend sales about a week after concerns over Losartan impuriti